San Mateo, CA, United States of America

James B C Mack

USPTO Granted Patents = 4 

Average Co-Inventor Count = 7.8

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2023-2025

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations by James B C Mack in HIV Therapeutics

Introduction

James B C Mack is a notable inventor based in San Mateo, CA, who has made significant contributions to the field of pharmaceuticals, particularly in the development of therapeutic compounds for HIV virus infection. With a total of four patents to his name, Mack's work focuses on innovative solutions to combat Retroviridae infections, including HIV.

Latest Patents

Mack's latest patents include groundbreaking therapeutic compounds aimed at treating HIV virus infections. The disclosures relate to specific compounds and pharmaceutical compositions that can be utilized for the treatment or prevention of Retroviridae infections. These compounds and compositions are designed to provide effective methods for managing HIV, showcasing Mack's commitment to advancing medical science.

Career Highlights

James B C Mack is currently associated with Gilead Sciences, Inc., a leading biopharmaceutical company known for its focus on antiviral drugs. His work at Gilead has allowed him to contribute to the development of innovative therapies that address critical health challenges.

Collaborations

Mack collaborates with talented professionals in his field, including Julie Farand and Tezcan Guney. These partnerships enhance the research and development process, fostering an environment of innovation and creativity.

Conclusion

James B C Mack's contributions to HIV therapeutics through his patents and work at Gilead Sciences, Inc. highlight his dedication to improving health outcomes for individuals affected by Retroviridae infections. His innovative approach continues to inspire advancements in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…